Brief: ImmuCell Corporation Q2 EPS USD 0.06
14/08/2025 21:05
Aug 14 (Reuters) - ImmuCell Corporation Q2 product sales USD 6.445 million. Q2 net income USD 502 thousand Q2 operating expenses USD 2.248 million Q2 pretax profit USD 504 thousand Q2 basic EPS USD 0.06
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year